SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cel-Sci Corp (AMEX:CVM) (was HIV)
CVM 6.660+0.5%Nov 14 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Shutters who wrote (2199)11/6/1998 10:07:00 AM
From: Tom Shutters  Read Replies (1) of 2836
 
"Programme on AIDS vaccine on the anvil"

"The presence of top-notch scientists from different parts of the world at the 10th international congress on immunology, which is currently under way here, is being used to evolve a national programme for the development of vaccine against the dreaded HIV virus."...

...In an informal chat, Dr. Esparza said that besides efforts to develop an indigenous vaccine, India could also contribute to endeavours in other parts of the world, particularly by helping in the testing of the various candidate vaccines that were presently at different stages of trial."

"He assured that it would not create any problem. All steps would be taken to ensure utmost safety. Indians would certainly not be treated as guinea pigs, he added and emphasised that the candidate vaccines that were under trial were being tested only after considering all safety parameters."

"Already, one candidate vaccine has entered the phase three trial this year for assessment of efficacy after undergoing rigorous testing for safety and immunogenicity in phase I and II trials. In addition, two candidate vaccines have entered phase II trial and 25 have undergone phase I trial, he added."

webpage.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext